KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Other financing activities: 2021-2024

Historic Other financing activities for Ginkgo Bioworks Holdings (DNA) over the last 1 years, with Sep 2024 value amounting to -$4,000.

  • Ginkgo Bioworks Holdings' Other financing activities fell 300.00% to -$4,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $1.6 million, marking a year-over-year increase of 90.20%. This contributed to the annual value of $59.9 million for FY2021, which is N/A change from last year.
  • According to the latest figures from Q3 2024, Ginkgo Bioworks Holdings' Other financing activities is -$4,000, which was down 100.66% from $604,000 recorded in Q4 2023.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Other financing activities peaked at $34.1 million during Q3 2021, and registered a low of -$88,000 during Q3 2022.
  • Over the past 3 years, Ginkgo Bioworks Holdings' median Other financing activities value was -$1,000 (recorded in 2023), while the average stood at $300,800.
  • Its Other financing activities has fluctuated over the past 5 years, first skyrocketed by 1,582.09% in 2022, then plummeted by 300.00% in 2024.
  • Over the past 4 years, Ginkgo Bioworks Holdings' Other financing activities (Quarterly) stood at -$67,000 in 2021, then soared by 1,582.09% to $993,000 in 2022, then tumbled by 39.17% to $604,000 in 2023, then plummeted by 300.00% to -$4,000 in 2024.
  • Its Other financing activities stands at -$4,000 for Q3 2024, versus $604,000 for Q4 2023 and -$1,000 for Q3 2023.